Drugs

Papers
(The H4-Index of Drugs is 57. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments502
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression464
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema375
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments236
Aprocitentan: First Approval210
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled,186
Senaparib: First Approval178
Targeting DNA Damage Response Deficiency in Thoracic Cancers166
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using142
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations141
Teclistamab: First Approval139
Epcoritamab: First Approval137
Eftrenonacog Alfa: A Review in Haemophilia B128
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”122
New Therapies on the Horizon for Primary Biliary Cholangitis121
Spesolimab for the Treatment of Generalized Pustular Psoriasis118
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences115
Vorasidenib: First Approval107
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial104
Ivarmacitinib Sulfate: First Approval103
Cosibelimab: First Approval102
QT Prolongation and Risk of Death with the Use of Methadone for Chronic Cancer and Noncancer Pain: Myths or Reality?101
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine100
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer99
Acoltremon: First Approval95
Androgenetic Alopecia: Therapy Update95
Drugs in Development to Manage Acute Pain95
Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms88
Atogepant: First Approval87
Lenacapavir: First Approval87
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies84
Repotrectinib: First Approval82
Danicopan: First Approval82
Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis81
Olipudase Alfa: First Approval81
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?81
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure81
Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema78
Mazdutide: First Approval78
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection77
Cancer Pain Treatment Strategies in Patients with Cancer75
Olverembatinib: First Approval74
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification69
Mosunetuzumab: First Approval68
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?67
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids64
Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections64
Managing Burning Mouth Syndrome: Current and Future Directions64
Correction to: Tapinarof Cream 1%: First Approval63
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?63
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough61
Correction to: Prevention and Treatment of Monkeypox60
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes60
Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in Pharmacology59
Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis59
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options58
Pozelimab: First Approval58
Ifupinostat: First Approval57
The Place of Cannabinoids in the Treatment of Gynecological Pain57
Sunvozertinib: First Approval57
Tovorafenib: First Approval57
0.10282301902771